Margot Geerts Selected Research

Small Fiber Neuropathy

1/2022	Follow-up Author Response: Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.
10/2021	Author Response: Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.
10/2021	Author Response: Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.
10/2021	Author Response: Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.
1/2021	Intravenous Immunoglobulin Therapy in Patients With Painful Idiopathic Small Fiber Neuropathy.
1/2020	Differential effect of lacosamide on Nav1.7 variants from responsive and non-responsive patients with small fibre neuropathy.
1/2019	Lacosamide in patients with Nav1.7 mutations-related small fibre neuropathy: a randomized controlled trial.
1/2016	Intravenous immunoglobulin therapy for small fiber neuropathy: study protocol for a randomized controlled trial.
1/2016	Efficacy, safety, and tolerability of lacosamide in patients with gain-of-function Nav1.7 mutation-related small fiber neuropathy: study protocol of a randomized controlled trial-the LENSS study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Margot Geerts Research Topics

Disease

9	Small Fiber Neuropathy 01/2022 - 01/2016
5	Pain (Aches) 01/2021 - 01/2016
1	Body Weight (Weight, Body) 01/2021

Drug/Important Bio-Agent (IBA)

6	Intravenous Immunoglobulins (IVIG)FDA Link 01/2022 - 01/2016
3	Lacosamide FDA Link 01/2020 - 01/2016
2	Voltage-Gated Sodium ChannelsIBA 01/2020 - 01/2019
1	Saline SolutionIBA 01/2021
1	Sodium Channels (Sodium Channel)IBA 01/2020
1	Pharmaceutical PreparationsIBA 01/2020
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2019
1	NAV1.7 Voltage-Gated Sodium ChannelIBA 01/2016

Therapy/Procedure

7	Therapeutics 01/2022 - 01/2016